Pelham, United States
VentriFlo Inc, a Health Care and Medical Devices startup, is pioneering a groundbreaking blood pumping system, VentriFlo® True Pulse Pumps™, to revolutionize cardiac and pulmonary support for pediatric and adult patients during CPB surgery and in the ICU for pulsatile VA ECMO. With a focus on achieving superior outcomes, reducing costs, and enhancing safety, VentriFlo Inc aims to disrupt the traditional methods of blood flow support in critical care settings.
The VentriFlo True Pulse Pump, though still in the development phase and not yet cleared for human use, holds immense potential to transform the landscape of cardiovascular and critical care medicine. As of 2019, VentriFlo Inc, headquartered in the United States, stands as a beacon of innovation in the realm of medical technology. With its patented technology and trademarks, including "Blood Flow The Way It Should Be," VentriFlo Inc is at the forefront of driving change in the medical devices industry.
As of now, there is no publicly available information about the last investment or the investors backing VentriFlo Inc. However, given the level of innovation and potential impact demonstrated by their pioneering work, VentriFlo Inc may attract substantial interest from venture capital firms and investors seeking to support disruptive advancements in healthcare technology.
